SPECIFIC PHARMA A/S
Core data
Name | SPECIFIC PHARMA A/S |
Address | Borgmester Christiansens Gade 40, 2450, København SV |
Founded | Sep 15, 2010 |
Employees (CVR) | 40 |
Locations (P-units) | 1View locations |
Website | https://specificpharma.com/ |
Branch | Engroshandel med medicinalvarer og sygeplejeartikler (464610) |
Name | SPECIFIC PHARMA A/S |
Address | Borgmester Christiansens Gade 40, 2450, København SV |
Founded | Sep 15, 2010 |
Employees (CVR) | 40 |
Locations (P-units) | 1View locations |
Website | https://specificpharma.com/ |
Branch | Engroshandel med medicinalvarer og sygeplejeartikler (464610) |
Keep track of SPECIFIC PHARMA A/S
Description
Specific Pharma is a European market leader in unlicensed medicines and medicines for special purposes, including clinical trials and drug shortages. It helps patients with unmet medical needs by providing the right medicine in a timely manner.
Specific Pharma helps healthcare professionals and patients gain access to unavailable human and veterinary medicines. It sources and imports medicines through a network of health authorities, healthcare professionals, suppliers, and others, including for named-patient, compassionate-use, and special-permit procedures.
Company's own description on virk.dk
Selskabets hovedaktivitet består i sourcing og distribution af speciallægemidler til hospitaler, apoteker og internationale samarbejdspartnere samt håndtering af kliniske forsyninger (CTSM).
Products & services
Access to unlicensed medicines · Access to medicines for clinical trials · Access to medicines during drug shortages · Sourcing of human medicines · Sourcing of veterinary medicines · Import of medicines · Named-patient, compassionate-use, and special-permit procedures
Industries
Healthcare · Pharmaceuticals
Customer types
Healthcare professionals · Patients · Pharmacies
Financials
| Reporting period | 2025/261 Feb 2025 - 31 Jan 2026DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 157,797,000 | ||||||||
| Gross profit | 38,182,000 | ||||||||
| Operating profit | 15,191,000 | ||||||||
| Profit before tax | 19,485,000 | ||||||||
| Net income | 15,192,000 | ||||||||
| Total assets | 115,179,000 | ||||||||
| Equity | 98,645,000 | ||||||||
| Avg. employees | 37 | ||||||||
2018–2026 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
From specificpharma.com
| Contact | Phone | |
|---|---|---|
| OUR FOCUS | +45 3645 ****Show full | — |
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Henrik Kaastrup | Roles Board | TitlesBESTYRELSESMEDLEM |
| Kasper Casparij Yde | Roles Board | TitlesBESTYRELSESMEDLEM |
| Ken Rasmussen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Kristine Sakstrup Haag | Roles Board | TitlesFORMAND |
| Søren Vesti Esbensen | Roles Board | TitlesSUPPLEANT |
| Uffe Kåre Jensen | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Forvis Mazars Statsautoriseret Revisionspartnerselskab | AuditorKarsten Vedel | Rolestatsaut. revisor | FromJun 26, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromSep 15, 2014 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇩🇪PHOENIX International Holdings GmbH | Ownership through | 100 % |